Nature Communications (Sep 2021)
Magnetothermal nanoparticle technology alleviates parkinsonian-like symptoms in mice
Abstract
Deep-brain stimulation ameliorates parkinsonian symptoms, but it usually requires permanent implantation of hardware and connectors. Here, the authors show magnetothermal neuromodulation through the activation of TRPV1 can improve locomotor deficits in mouse models of Parkinson’s disease.